Evaluation of HBV DNA decay kinetics in patients containing both rtM204V/I mutant and wild-type HBV subpopulations during tenofovir DF (TDF) monotherapy or combination therapy with emtricitabine (FTC)/TDF
Version of Record online: 23 MAY 2014
© 2014 Wiley Periodicals, Inc.
Journal of Medical Virology
Volume 86, Issue 9, pages 1473–1481, September 2014
How to Cite
Liu, Y., Fung, S., Gane, E. J., Dinh, P., Flaherty, J. F., Svarovskaia, E. S., Miller, M. D. and Kitrinos, K. M. (2014), Evaluation of HBV DNA decay kinetics in patients containing both rtM204V/I mutant and wild-type HBV subpopulations during tenofovir DF (TDF) monotherapy or combination therapy with emtricitabine (FTC)/TDF. J. Med. Virol., 86: 1473–1481. doi: 10.1002/jmv.23982
- Issue online: 9 JUL 2014
- Version of Record online: 23 MAY 2014
- Manuscript Accepted: 7 FEB 2014
- Gilead Sciences, Inc.
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.